Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Atrial flutter in a patient with Alzheimer dementia treated by rivastigmine.

Hsu YC, Chao CY, Chang HA, Hwang SY, Tzeng NS.

J Neuropsychiatry Clin Neurosci. 2013 Spring;25(2):E25-6. doi: 10.1176/appi.neuropsych.12030063. No abstract available.

PMID:
23686050
2.

A rivastigmine-precipitated manic episode in a patient with Alzheimer-type dementia.

Tseng WS, Tzeng NS.

Int Psychogeriatr. 2012 Oct;24(10):1697-9. doi: 10.1017/S1041610212000701. Epub 2012 Apr 26.

PMID:
22717054
3.

Rivastigmine transdermal patches in the treatment of dementia in Alzheimer's disease in adults with Down syndrome-pilot study.

Prasher VP, Sachdeva N, Adams C, Haque MS.

Int J Geriatr Psychiatry. 2013 Feb;28(2):219-20. doi: 10.1002/gps.3821. No abstract available.

PMID:
23296840
4.

Effects of body weight on tolerability of rivastigmine transdermal patch: a post-hoc analysis of a double-blind trial in patients with Alzheimer disease.

Lee JH, Sevigny J.

Alzheimer Dis Assoc Disord. 2011 Jan-Mar;25(1):58-62. doi: 10.1097/WAD.0b013e3181f32829.

PMID:
20975519
5.

The ACTION study: methodology of a trial to evaluate safety and efficacy of a higher dose rivastigmine transdermal patch in severe Alzheimer's disease.

Farlow MR, Grossberg G, Gauthier S, Meng X, Olin JT.

Curr Med Res Opin. 2010 Oct;26(10):2441-7. doi: 10.1185/03007995.2010.513849.

PMID:
20828359
6.

Discontinuation of rivastigmine in routine clinical practice.

Frankfort SV, Appels BA, de Boer A, Tulner LR, van Campen JP, Koks CH, Beijnen JH.

Int J Geriatr Psychiatry. 2005 Dec;20(12):1167-71.

PMID:
16315150
7.

Rivastigmine for Alzheimer's disease.

[No authors listed]

Drug Ther Bull. 2000 Feb;38(2):15-6. Review.

PMID:
10829350
8.

Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease.

Bullock R, Bergman H, Touchon J, Gambina G, He Y, Nagel J, Lane R.

Curr Med Res Opin. 2006 Mar;22(3):483-94.

PMID:
16574032
9.

A 24-week, multicentre, open evaluation of the clinical effectiveness of the rivastigmine patch in patients with probable Alzheimer's disease.

Articus K, Baier M, Tracik F, Kühn F, Preuss UW, Kurz A.

Int J Clin Pract. 2011 Jul;65(7):790-6. doi: 10.1111/j.1742-1241.2011.02713.x. Epub 2011 Jun 6.

PMID:
21645184
10.

Prolonged QT interval with rivastigmine.

Walsh E, Dourish J.

Br J Psychiatry. 2002 May;180:466. No abstract available.

11.

Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial.

Farlow M, Potkin S, Koumaras B, Veach J, Mirski D.

Arch Neurol. 2003 Jun;60(6):843-8.

PMID:
12810489
12.

Spontaneous rupture of oesophagus (Boerhaave's syndrome) related to rivastigmine.

Babic T, Banfic L, Papa J, Barisic N, Jelincic Z, Zurak N.

Age Ageing. 2000 Jul;29(4):370-1. No abstract available.

13.

Rivastigmine for dementia associated with Parkinson's disease.

Morgan J, Sethi KD.

Curr Neurol Neurosci Rep. 2005 Jul;5(4):263-5. No abstract available.

PMID:
15987609
14.

[Rivastigmine for Alzheimer disease; evaluation of preliminary results and of structured assessment of efficacy].

Schölzel-Dorenbos CJ.

Ned Tijdschr Geneeskd. 2002 Mar 9;146(10):494. Dutch. No abstract available.

PMID:
11913117
16.

Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer's disease: a multicenter, randomized, open-label, parallel-group study.

Choi SH, Park KW, Na DL, Han HJ, Kim EJ, Shim YS, Lee JH; Expect Study Group.

Curr Med Res Opin. 2011 Jul;27(7):1375-83. doi: 10.1185/03007995.2011.582484. Epub 2011 May 12.

PMID:
21561398
17.

Rivastigmine in the treatment of Alzheimer's disease: an update.

Onor ML, Trevisiol M, Aguglia E.

Clin Interv Aging. 2007;2(1):17-32. Review.

18.

Different responses to rivastigmine in subcortical vascular dementia and multi-infarct dementia.

Moretti R, Torre P, Antonello RM, Cazzato G, Pizzolato G.

Am J Alzheimers Dis Other Demen. 2008 Apr-May;23(2):167-76. doi: 10.1177/1533317507312558. Epub 2008 Jan 9.

PMID:
18184948
19.

A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer's disease: a post hoc analysis.

Farlow MR, Alva G, Meng X, Olin JT.

Curr Med Res Opin. 2010 Feb;26(2):263-9. doi: 10.1185/03007990903434914.

PMID:
19929593
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk